Table 1b.
Cerebellum plasmalogen mass in SSADH deficient patient and control group
| nmol/g ww | mol % | |||||
|---|---|---|---|---|---|---|
|
|
||||||
| Patient | Mean (control) | SD | Patient | Mean (control) | SD | |
|
|
||||||
| EtnGpl | 5052 | 5999 | 1693 | 42.2% | 50.3% | 6.5% |
| PlsEtn | 6913 | 6229 | 3063 | 57.8% | 49.7% | 6.5% |
| ChoGpl | 10464 | 10853 | 3079 | 87.6% | 90.0% | 1.8% |
| PlsCho | 1483 | 1247 | 595 | 12.4% | 10.0% | 1.8% |
| n = 1 | n = 3 | |||||
Mass values are expressed as nmol phosphorus/gram wet weight tissue and represent mean±SD of control and patient values. Molar composition values are expressed as mol % of total phosphorus. n = 2–4.
*
indicates significance between patient and control group, 2 SD from control mean.